Highlights•The placenta is a reservoir of stem cells with minimal ethical concerns.•The
placenta is a source of haematopoietic stem cells during fetal development.•The …

Nearly 1.5 million people in the US live with a spinal cord injury (SCI). The cost to the
healthcare system is estimated at over $10 billion annually likely because over 65% of SCIs …

Ischemic stroke is a debilitating disease for which there are currently no effective treatments
besides the clot-buster, tissue plasminogen activator (t-PA), which is administered to less …

Human amniotic epithelial cells (HAEs) have a low immunogenic profile and possess potent
immunosuppressive properties. HAEs also have several characteristics similar to stem cells …

Human amnion epithelial cells (hAECs) derived from term or pre-term amnion membranes
have attracted attention from researchers and clinicians as a potential source of cells for …

Human amniotic epithelial cells (hAECs) derived from placental tissue have received
significant attention as a promising tool in regenerative medicine. Several studies …

* Correspondence should be addressed to: Claude CA Bernard, Monash Immunology and
Stem Cell Laboratories, Building 75, Monash University, Wellington Rd, Clayton, Victoria …

The amnion muscle combined graft (AMCG) conduits showed good clinical results in
peripheral nerves gap repair. It combines the human amniotic membrane with autologous …

The severely preterm infant receives a multitude of life-saving interventions, many of which
carry risks of serious side effects. Cell therapy is an important and promising arm of …

Human embryonic stem cells (hESCs) are pluripotent cells that have the potential to
differentiate into the three germ layers and possibly all tissues of the human body. To fulfil …